(Q42978644)

12 November 2017

Elinogrel: pharmacological principles, preclinical and early phase clinical testing (English)

1 reference

12 November 2017

1 reference

3

Dominick J Angiolillo

1 reference

12 November 2017

Masafumi Ueno

1

1 reference

PubMed ID

20608816

12 November 2017

Sunil V Rao

series ordinal

2

1 reference

12 November 2017

1 July 2010

1 reference

12 November 2017

1 reference

12 November 2017

6

1 reference

12 November 2017

4

1 reference

12 November 2017

445-453

1 reference

Basic principles of platelet biology and clinical implications

12 November 2017

1 reference

Adenosine diphosphate as a mediator of platelet aggregation in vivo: an editorial view.

21 January 2018

1 reference

The P2 receptors in platelet function.

21 January 2018

1 reference

Regulation of platelet functions by P2 receptors

21 January 2018

1 reference

Scientific and therapeutic insights into the role of the platelet P2Y12 receptor in thrombosis

21 January 2018

1 reference

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study

21 January 2018

1 reference

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 January 2018

1 reference

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

21 January 2018

1 reference

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

21 January 2018

1 reference

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

21 January 2018

1 reference

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

21 January 2018

1 reference

Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives

21 January 2018

1 reference

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

21 January 2018

1 reference

Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myoc

21 January 2018

1 reference

Prasugrel in acute coronary syndrome patients undergoing percutaneous coronary intervention.

21 January 2018

1 reference

Prasugrel versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention

21 January 2018

1 reference

Mechanism of action and clinical development of ticagrelor, a novel platelet ADP P2Y12 receptor antagonist

21 January 2018

1 reference

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

Cangrelor: a review on its mechanism of action and clinical development.

21 January 2018

1 reference

Platelet inhibition with cangrelor in patients undergoing PCI.

21 January 2018

1 reference

Intravenous platelet blockade with cangrelor during PCI.

21 January 2018

1 reference

The reversible P2Y antagonist cangrelor influences the ability of the active metabolites of clopidogrel and prasugrel to produce irreversible inhibition of platelet function

21 January 2018

1 reference

The effect of elinogrel on high platelet reactivity during dual antiplatelet therapy and the relation to CYP2C19*2 genotype: first experience in patients

21 January 2018

1 reference

Mathematical analysis of mural thrombogenesis. Concentration profiles of platelet-activating agents and effects of viscous shear flow

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FCA.10.67

1 reference

12 November 2017

1 reference

PubMed ID

20608816